Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Ontology highlight
ABSTRACT: Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
PROVIDER: PRJNA564119 | ENA |
REPOSITORIES: ENA
ACCESS DATA